Hightide Therapeutics

Developer of small molecule based therapeutics for the treatment of liver, gastrointestinal, and metabolic disorders

placeRockville, Maryland, United States calendar_todayFounded 2011 groups68 employees language hightidetx.com

Social engagement

Social engagement: 1.7K social following, 7 posts in the last 12 months — around the industry typical range.

Investor mix

8 investors on record; lead investors include Tcmhealthcare, CITIC Securities, Cowin Capital, Blue Ocean Capital.

Investor typeCountShare
Venture capital113%
Private equity338%
Other / undisclosed450%

Recent activity

8 Jun 2026
Product launch
HTD1801
29 May 2026
Event
63rd Congress of the European Renal Association (ERA 2026)
2 Feb 2026
Leadership hire
Chief Medical Officer
Coming soon